Severe asthma can have a devastating effect on sufferers, affecting their ability to work or go to school and to lead normal lives. It is difficult to treat because it is not a single disease entity.

When presented with the same clinical information about a series of pediatric asthma patients, specialists varied in the conclusions they drew. The 14 pediatric pulmonologists and allergists in this ...

Researchers sought to characterize the effect of the changes in the GINA 2019 recommendations in a real-world patient setting. This article is part of MPR’s coverage of the CHEST Virtual 2020 meeting.

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Self-assessment of asthma and a stronger doctor-patient relationship can improve asthma outcomes. Evidence for the influence of patient enablement on quality of life and the control of asthma is ...

The introduction of the Global Initiative for Asthma 2019 guidelines significantly improved treatment of children with mild asthma, according to one study. Increased registrars’ knowledge of the ...

Chronic obstructive pulmonary disease (COPD)and asthma are conditions that exact a tremendoustoll on patients, providers, and society. The substantialincrease in the prevalence of both conditions ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Objective: The asthma practice guidelines developed by the National Institutes of Health include a system for classifying asthma severity. The goal of the present study was to assess the interrater ...